
Professor Dobromir Dobrev
University Hospital of Essen (Ruhr), Essen (Germany)
Membership:
FESC Member
EHRA Member
HFA Member
Follow
Biography
Dr. Dobrev is Full Professor and Director of Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany. He also serves as Adjunct Full Professor of Medicine at Montreal Heart Institute, University of Montreal, Canada and Baylor College of Medicine, Houston, USA. His main research interest is the molecular basis of disease-related cardiac remodeling and arrhythmias and identification and validation of novel antiarrhythmic targets. Dr. Dobrev is recognized nationally and internationally as an expert in cardiovascular research.
Contributor content
Session
Improving equity in stroke prevention and treatment: focus on sex and ethnic differences
29 August 2025
Session
Regulatory aspects
12 December 2024
Session
Combined antithrombotic therapy in patients with obstructive coronary artery disease
3 November 2023
Session
Antithrombotic therapy in special populations
2 November 2023
Session
Anticoagulation for stroke prevention in older patients with atrial fibrillation
29 June 2023
Session
Antiarrhythmics: challenges to prescription of antiarrhythmics in older patients
28 June 2023
Session
Issues in clinical trials: Devices
8 December 2022
Session
Insight into atrial physiology and pathology
1 September 2019
Session
Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error
19 March 2019
Session
Molecular basis for arrhythmias and beyond
22 April 2018

